Evaluation of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction

December 14, 2023 updated by: Ahmed EmadElden Mohamed, Assiut University

Assessment of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction: Pre and Post Thyroid Treatment

  1. Evaluate psychiatric symptoms in patients with thyroid dysfunction.
  2. Investigate effect of treatment on psychiatric symptoms after 2 months.

Study Overview

Status

Not yet recruiting

Detailed Description

Thyroid dysfunction is associated with psychiatric symptoms in addition to endocrinal manifestations.

The study aims to evaluate the prevalence of psychiatric symptoms in patients with thyroid dysfunction and investigate the response after thyroid treatment.

Study Type

Observational

Enrollment (Estimated)

85

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients newly diagnosed as having thyroid dysfunction.

Description

Inclusion Criteria:

  • Patients newly diagnosed as having thyroid dysfunction.

Exclusion Criteria:

  • Patients with other endocrinological disorders or significant medical or neurological diseases.
  • Alcohol or substance abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect of thyroid treatment on psychiatric symptoms
Time Frame: 2 months
Investigate the effect of thyroid treatment on psychiatric symptoms associated with thyroid dysfunction.
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Romany Hosny Gabra Henein, professor, Assiut University
  • Study Director: Khaled Ahmed Mohamed, Professor, Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2024

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

December 5, 2023

First Submitted That Met QC Criteria

December 14, 2023

First Posted (Actual)

December 29, 2023

Study Record Updates

Last Update Posted (Actual)

December 29, 2023

Last Update Submitted That Met QC Criteria

December 14, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Psychiatry & thryoid disorders

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

3
Subscribe